TREM-1: A new regulator of innate immunity in sepsis syndrome
- 1 May 2001
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 7 (5) , 530-532
- https://doi.org/10.1038/87846
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A CD14-independent LPS receptor clusterNature Immunology, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene ExpressionThe Journal of Immunology, 2001
- Human Nod1 Confers Responsiveness to Bacterial LipopolysaccharidesJournal of Biological Chemistry, 2001
- Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and MonocytesThe Journal of Immunology, 2000
- Critical Roles of Toll-Like Receptors in Host DefenseCritical Reviews in Immunology, 2000
- Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic ShockMolecular Medicine, 1999
- Transport of Bacterial Lipopolysaccharide to the Golgi ApparatusThe Journal of Experimental Medicine, 1999
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999
- Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharideProceedings of the National Academy of Sciences, 1999